51 related articles for article (PubMed ID: 17125617)
1. [Expression of angiotensinogen during development and spontaneous reversal of hepatic fibrosis].
Yang L; Liu HL; Huo L; Wang L
Zhonghua Gan Zang Bing Za Zhi; 2006 Nov; 14(11):845-6. PubMed ID: 17125617
[No Abstract] [Full Text] [Related]
2. [Expression of p75 and hepatic stellate cell apoptosis during spontaneous resolution of rat liver fibrosis].
Wang P; Liu HL
Zhonghua Gan Zang Bing Za Zhi; 2006 Aug; 14(8):628-9. PubMed ID: 16938185
[No Abstract] [Full Text] [Related]
3. Renin and angiotensinogen mRNA expression in the kidneys of rats subjected to long-term bile duct ligation.
Ubeda M; Matzilevich MM; Atucha NM; García-Estañ J; Quesada T; Tang SS; Ingelfinger JR
Hepatology; 1994 Jun; 19(6):1431-6. PubMed ID: 8188173
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effect of tetrandrine on collagen synthesis of experimental hepatic fibrosis in rats].
He Y; Xu K; Zhang Q; Dai W; Xu Z; Liu B
Zhongguo Zhong Yao Za Zhi; 1996 Mar; 21(3):177-9, 192. PubMed ID: 9206262
[No Abstract] [Full Text] [Related]
5. Vasoactive intestinal peptide down-regulates the intrahepatic renin-angiotensin system in the anaesthetized rat.
Ye VZ; Duggan KA
Clin Sci (Lond); 2000 Sep; 99(3):201-6. PubMed ID: 11787472
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the intrahepatic renin-angiotensin system after stimulation of the gastric sodium monitor in the rat.
Ye VZ; Duggan KA
Clin Sci (Lond); 2000 Jan; 98(1):57-64. PubMed ID: 10600659
[TBL] [Abstract][Full Text] [Related]
7. Effects of perindopril and valsartan on expression of transforming growth factor-beta-Smads in experimental hepatic fibrosis in rats.
Xu W; Song S; Huang Y; Gong Z
J Gastroenterol Hepatol; 2006 Aug; 21(8):1250-6. PubMed ID: 16872305
[TBL] [Abstract][Full Text] [Related]
8. [The expressions of platelet-derived growth factor beta receptor and p-ERK1/2 in livers of rats with experimental hepatic fibrosis].
Shi BS; Wu J; Yang Q; Cheng ML
Zhonghua Gan Zang Bing Za Zhi; 2007 Aug; 15(8):619-20. PubMed ID: 17711638
[No Abstract] [Full Text] [Related]
9. Alterations of intrarenal renin-angiotensin and nitric oxide systems in streptozotocin-induced diabetic rats.
Choi KC; Kim NH; An MR; Kang DG; Kim SW; Lee J
Kidney Int Suppl; 1997 Sep; 60():S23-7. PubMed ID: 9285898
[No Abstract] [Full Text] [Related]
10. [Effect of TGFbeta1 vaccine on the expression of MMP-2 and TIMP-2 in rats with liver fibrosis].
Lu MQ; Chen YP; Pan CW; Wang XD
Zhonghua Gan Zang Bing Za Zhi; 2006 Sep; 14(9):692-4. PubMed ID: 16995990
[No Abstract] [Full Text] [Related]
11. Treatment of experimental hepatic fibrosis by combinational delivery of urokinase-type plasminogen activator and hepatocyte growth factor genes.
Lin Y; Xie WF; Chen YX; Zhang X; Zeng X; Qiang H; Chen WZ; Yang XJ; Han ZG; Zhang ZB
Liver Int; 2005 Aug; 25(4):796-807. PubMed ID: 15998431
[TBL] [Abstract][Full Text] [Related]
12. [Effect of Hovenia dulcis extract on expression of MMP-13 and TIMP-1 in hepatic tissue].
Liu XL; Zhnag H; Wang F
Zhongguo Zhong Yao Za Zhi; 2006 Jul; 31(13):1097-100. PubMed ID: 17048613
[TBL] [Abstract][Full Text] [Related]
13. [Protective effect of ganfukang capsule on hepatocytes in rats with experimental hepatic fibrosis].
Che Y; Xu T; Jiang M; Jia Y
Zhong Yao Cai; 2004 Jun; 27(6):428-9. PubMed ID: 15524298
[TBL] [Abstract][Full Text] [Related]
14. [Angiotensinogen synthesis rate of the isolation-perfused rat liver in experimental liver damage].
Beyer JC; Wernze H; Gallenkamp H
Verh Dtsch Ges Inn Med; 1975; 81():1339-41. PubMed ID: 1226957
[No Abstract] [Full Text] [Related]
15. A combination of Ang II and carbon tetrachloride accelerates process of hepatic fibrosis.
Zhou X; Li D; Li X; Lu H; Zhang W
Chin Med J (Engl); 2003 Jan; 116(1):62-5. PubMed ID: 12667390
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of leflunomide on hepatic fibrosis induced by CCl4 in rats.
Yao HW; Li J; Chen JQ; Xu SY
Acta Pharmacol Sin; 2004 Jul; 25(7):915-20. PubMed ID: 15210065
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats.
Yue HY; Yin C; Hou JL; Zeng X; Chen YX; Zhong W; Hu PF; Deng X; Tan YX; Zhang JP; Ning BF; Shi J; Zhang X; Wang HY; Lin Y; Xie WF
Gut; 2010 Feb; 59(2):236-46. PubMed ID: 19671543
[TBL] [Abstract][Full Text] [Related]
18. Mineralocorticoid receptor antagonist spironolactone prevents pig serum-induced hepatic fibrosis in rats.
Fujisawa G; Muto S; Okada K; Kusano E; Ishibashi S
Transl Res; 2006 Sep; 148(3):149-56. PubMed ID: 16938653
[TBL] [Abstract][Full Text] [Related]
19. Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis.
Rockey DC; Chung JJ
J Investig Med; 1994 Dec; 42(4):660-70. PubMed ID: 8521029
[TBL] [Abstract][Full Text] [Related]
20. Hepatic fibrosis as a predictor of hepatic regenerative activity after partial hepatectomy in the rat.
MacIntosh EL; Gauthier T; Pettigrew NM; Minuk GY
Hepatology; 1993 Feb; 17(2):307-9. PubMed ID: 8428729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
